Answers are grounded in this paper and cite their sources.
A systematic methodology, able to assess risk and predict clinical safety and efficacy of Substances of Human Origin' (SoHO) has been developed. The model consists of a risk based approach taking into account factors such as novelty of the product, preparation process, clinical indication, and its technical complexity.
No takes yet. Share an insight, caveat, or question.
Trias et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: